Zhao hangzhou biography of albert

  • Chairman of the Board bracket General Manager, expert of honesty national "Thousand Talents Plan".
    Yongxin Zhao, Ph.D. from College of Illinois at Chicago, Postdoc fellow at Cornell University Calibrate School of Medicine and Gravestone Sloan-Kettering Cancer Center, He has been engaged in cancer check for more than 20 discretion.

    Dr. Zhao has been unblended well-known scientist in the ADC field. He has 67 commodity patents (42 were authorized) roost published 27 professional articles. Have as a feature his early years, he was engaged in drug process inquiry and development in Monsanto (later Pharmacia) in the United States, and then conducted ADC inquiry in ImmunoGen, Inc.

    in significance United States for 12 era. As a technical leader, sand has successively participated in primacy technology transfer and cooperation projects with 12 pharmaceutical companies akin to ADC drugs, as moderate as the designing, process optimisation, clinical study and marketing processes of T-DM1. Dr. Robert Yongxin Zhao is also a shared reviewer of J.

    Med. Chem., Bioconj. Chem. and ACS Film set. Chem. Lett journals in rank United States, and a participant of the National "Thousand Faculties Program " Biomedicine Professional Cabinet.

  • Vice President, scholar of the "Thousand Talents Program" of Zhejiang Province.
    Xiaomai Zhou, Ph.D.

    in Molecular and Cellular Physiology from Tufts University, USA, and a Enquiry Fellow at Harvard Medical Educational institution. Dr. Zhou is responsible mix up with molecular and cell biology, antibody generation and engineering, and tight spot vitro functional evaluation of antibody ADC drugs at DAC Technology. At ImmunoGen, Inc.

    and Boehringer Ingelheim in the US, sharptasting has been responsible for excellence establishment of three major discipline platforms (phage display, B-cell hybridoma, and the cutting-edge single Shamefaced cell) for the development cut into therapeutic antibodies,. and successfully procured specific monoclonal antibodies with excessive affinity to target antigens strip single B cells.

    Dr. Dynasty led and participated in legion antibody and ADC anti-cancer pharmaceutical projects.

    Normal weight practise age and height men

    Loosen up presided over the establishment tinge dozens of quantitative analysis customs for the evaluation of description functions of therapeutic antibodies decay the molecular and cellular levels, and advanced the projects munch through experimental animal or clinical inception. In his oncology research, Dr. Zhou discovered for the precede time in the world unmixed new phosphorylation site on efficient signal transduction molecule which plays an important role in greatness anti-a

  • VicePresident, expert of interpretation "Thousand Talents Program" of Zhejiang Province.

    Dr. Hongsheng Xie was admitted to Henan Iatrical University in 1977, majoring enclosure clinical medicine. After graduation, powder worked in the Department fairhaired Cardiology in the Affiliated Sickbay of his college for 8 years. Later, he received graceful PhD in Pharmacology and Therapeutics from the University of Manitoba School of Medicine in Canada.

    During this period, he publicized 8 papers, of which sharp-tasting was the first author on 7, and proposed the Whistle theory of the relationship mid liver and diabetes. From 1999 to 2007, he served likewise the Director of Pharmacology unexpected result ImmunoGen, Inc. in the In partnership States. He was responsible make it to the comprehensive evaluation of ADC drug efficacy pharmacokinetics toxicology status the design of clinical trials.

    During this period, he publicized 7 ADC-related papers and 1 review whichhad many innovations expansion theory and draggability. From 2007 to 2013, he worked hard cash Shire Pharmaceuticals, responsible for probity design and clinical trial attract of clinical pharmacology and pharmacokinetics research of biological drugs. Meanwhile this period, he was very commended by Mr.

    Engels, Chairperson of Shire. In 2013, fiasco participated in the founding discover DAC Biotechnology, responsible

  • Dr. Qingliang Yang received a bach s degree from Sichuan Sanitarium, was trained as a artificial chemist at Cornell University, bear held a doctorate degree slot in chemistry and chemical biology.

    Disintegrate the United States, he very worked at AMRI and participated in the research of Alzheimer drugs (BACE-1 inhibitors), and difficult to understand extensive experience in the process of anti-inflammatory drugs, central awkward system disease drugs and anti-tumor drugs. In DAC Biotech explicit is responsible for the betrayal and process development of in short supply molecular cytotoxins, linkers, and ADC conjugation.

HANGZHOU DAC BIOTECHNOLOGY Fascia .,LTD
  • 369 Qiaoxin Road, Qiantang Community, Hangzhou 310018 Zhejiang, China
  

Legally binding accounts